乳腺浸润性微乳头状癌转移机制的研究进展

doi:10.11904/j.issn.1002-3070.2022.03.014

摘要/Abstract

摘要： 乳腺浸润性微乳头状癌(Invasive micropapillary carcinoma,IMPC)是一种罕见的乳腺癌组织病理学变异,约占所有乳腺癌的3%~8%。尽管IMPC的发病率较低,但与非特殊类型浸润性导管癌(Invasive ductal carcinoma of no special type,IDC-NST)相比,IMPC显示出更高的淋巴管浸润和淋巴结转移倾向。因此,了解其转移机制对于干预临床诊疗过程显得尤为重要。本文旨在综述IMPC的转移机制及相关临床证据,从而为IMPC的治疗提供新的思路。

关键词: 乳腺癌, 浸润性微乳头状癌, 转移机制

Abstract: Invasive micropapillary carcinoma(IMPC)of breast is a rare histopathological variant of breast cancer,accounting for approximately 3%-8% of all breast cancer.Compared with invasive ductal carcinoma of no special type(IDC-NST),although the incidence of IMPC is low,IMPC shows a tendency of lymphatic invasion and lymph node metastasis.Therefore,understanding its metastasis mechanism is particularly important for intervening in the clinical diagnosis and treatment process.This article aims to review the metastatic mechanism of IMPC and related to clinical evidence,so as to provide new ideas for the treatment of IMPC.

Key words: Breast cancer, Invasive micropapillary carcinoma, Mechanism of metastasis

中图分类号:

R730.5

刘婉莹, 庞达. 乳腺浸润性微乳头状癌转移机制的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 268-272.

LIU Wanying, PANG Da. Research progress on the mechanism of metastasis in invasive micropapillary carcinoma of the breast[J]. Journal of Practical Oncology, 2022, 36(3): 268-272.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2022.03.014

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2022/V36/I3/268

参考文献

1 Wang R,Li N,Wang XJ,et al.Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China[J].Ann Transl Med,2021,9(5):412.
2 Fisher ER,Palekar AS,Redmond C,et al.Pathologic findings from the national surgical adjuvant breast project(protocol no.4).VI.invasive papillary cancer[J].Am J Clin Pathol,1980,73(3):313-322.
3 Siriaunkgul S,Tavassoli FA.Invasive micropapillary carcinoma of the breast[J].Mod Pathol,1993,6(6):660-662.
4 Ye F,Yu P,Li N,et al.Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast:a meta-analysis of PSM studies[J].Breast,2020,51:11-20.
5 Fu L,Ikuo M,Fu XY,et al.Relationship between biologic behavior and morphologic features of invasive micropapillary carcinoma of the breast[J].Zhonghua Bing Li Xue Za Zhi,2004,33(1):21-25.
6 Yang YL,Liu BB,Zhang X,et al.Invasive micropapillary carcinoma of the breast:an update[J].Arch Pathol Lab Med,2016,140(8):799-805.
7 王月辰,汤璐,邢华,等.乳腺浸润性微乳头状癌临床病理及诊治的研究进展[J].中国普外基础与临床杂志,2019,26(5):636-640.
8 Guo X,Chen L,Lang R,et al.Invasive micropapillary carcinoma of the breast:association of pathologic features with lymph node metastasis[J].Am J Clin Pathol,2006,126(5):740-746.
9 Acs G,Esposito NN,Rakosy Z,et al.Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma[J].Am J Surg Pathol,2010,34(11):1637.
10 Shi WB,Yang LJ,Hu X,et al.Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma:a population-based study from China[J].PLoS One,2014,9(6):e101390.
11 Marchiò C,Iravani M,Natrajan R,et al.Mixed micropapillary-ductal carcinomas of the breast:a genomic and immunohistochemical analysis of morphologically distinct components[J].J Pathol,2009,218(3):301-315.
12 Deman F,Punie K,Laenen A,et al.Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes[J].Breast Cancer Res Treat,2020,184(3):985-998.
13 Zhao C,Thompson BJ,Chen K,et al.The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44[J].Oncotarget,2019,10(61):6561-6576.
14 徐锦屏,沈卫达,李冰,等.HSPA5和CD44v6在乳腺癌组织中的表达及其诊断价值[J].海南医学,2019,30(4):424-426.
15 Umeda T,Ishida M,Murata S,et al.Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast:comparison with a concurrent conventional invasive carcinoma of no special type component[J].Breast Cancer,2016,23(6):869-875.
16 Badyal RK,Bal A,Das A,et al.Invasive micropapillary carcinoma of the breast:immunophenotypic analysis and role of cell adhesion molecules(CD44 and E-Cadherin)in nodal metastasis[J].Appl Immunohistochem Mol Morphol,2016,24(3):151-158.
17 Gamba CO,Rodrigues MA,Gomes DA,et al.The relationship between E-Cadherin and its transcriptional repressors in spontaneously arising canine invasive micropapillary mammary carcinoma[J].J Comp Pathol,2015,153(4):256-265.
18 Huang L,Ji H,Yin L,et al.High expression of plakoglobin promotes metastasis in invasive micropapillary carcinoma of the breast via tumor cluster formation[J].J Cancer,2019,10(12):2800-2810.
19 Wang XX,Liu BB,Wu X,et al.Loss of leucine zipper putative tumor suppressor 1(LZTS1)expression contributes to lymph node metastasis of breast invasive micropapillary carcinoma[J].Pathol Oncol Res,2015,21(4):1021-1026.
20 Zhang C,Wang L,Jin C,et al.Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1[J].Cell Death Dis,2021,12(2):224.
21 Hou X,Niu Z,Liu L,et al.miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression[J].Oncol Lett,2019,17(1):990-998.
22 Lin B,Du L,Li H,et al.Tumor-infiltrating lymphocytes:warriors fight against tumors powerfully[J].Biomed Pharmacother,2020,132:110873.
23 袁静萍,袁修学,阎红琳.肿瘤浸润淋巴细胞在乳腺癌肿瘤微环境中的角色[J].临床与实验病理学杂志,2018,34(12):1356-1359.
24 沈浩元,邓春燕,戴一菲,等.Fas、FasL蛋白与乳腺癌相关性的临床研究[J].中国现代普通外科进展,2017,20(12):948-951.
25 Lin EY,Pollard J W.Role of infiltrated leucocytes in tumour growth and spread[J].Br J Cancer,2004,90(11):2053-2058.
26 Guo X,Fan Y,Lang R,et al.Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast[J].Mod Pathol,2008,21(9):1101-1107.
27 Li S,Yang C,Zhai L,et al.Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast[J].Breast Cancer Res Treat,2012,136(1):77-87.
28 Marchiò C,Iravani M,Natrajan R,et al.Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast[J].J Pathol,2008,215(4):398-410.
29 Meng F,Liu B,Xie G,et al.Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast[J].Breast Cancer Res Treat,2017,166(2):383-392.
30 Dieci MV,Smutná V,Scott V,et al.Whole exome sequencing of rare aggressive breast cancer histologies[J].Breast Cancer Res Treat,2016,156(1):21-32.

[1]	杨子涵, 许守平, 庞达. 乳腺癌发生腋窝外三角组织转移特点与影响因素分析[J]. 实用肿瘤学杂志, 2022, 36(3): 226-232.
[2]	何伟丹, 李志高. FSIP1促进乳腺癌细胞迁移和侵袭并导致患者不良预后[J]. 实用肿瘤学杂志, 2022, 36(3): 233-238.
[3]	刘欣欣, 姚欣卉, 孙跃峰, 缪美琪, 陈晶. 乳腺癌微环境中趋化因子CCL20作用的研究进展[J]. 实用肿瘤学杂志, 2022, 36(3): 250-254.
[4]	杨姝娅, 刘文慧, 骆耐香. UCA1在乳腺癌中的研究现状和应用展望[J]. 实用肿瘤学杂志, 2022, 36(3): 263-267.
[5]	孙元元, 张苧之, 曹孟儒. 乳腺癌肺转移机制及治疗进展[J]. 实用肿瘤学杂志, 2022, 36(2): 173-177.
[6]	侯建勋, 王洪斌. 外泌体对乳腺癌诊疗一体化影响的研究进展[J]. 实用肿瘤学杂志, 2022, 36(2): 178-182.
[7]	陈赫, 王秋程, 程文. 自动乳腺超声诊断系统在乳腺癌方面的应用进展[J]. 实用肿瘤学杂志, 2022, 36(2): 193-196.
[8]	李伟华, 张广凤, 马骊骊, 何品, 王雯, 李顶夫. 基于TCGA数据库代谢相关基因构建乳腺癌预后模型[J]. 实用肿瘤学杂志, 2022, 36(1): 37-43.
[9]	曹世玉, 姜永冬. 基因表达与多基因检测以及生物标志物对Luminal A型乳腺癌预后的影响[J]. 实用肿瘤学杂志, 2022, 36(1): 89-93.
[10]	罗波, 张曲, 郑红梅, 梁新军, 周小妹, 吴新红. SRT联合拉帕替尼治疗HER2阳性乳腺癌脑转移疗效及预后分析[J]. 实用肿瘤学杂志, 2021, 35(6): 523-528.
[11]	史润泽, 李志高. 三阴性乳腺癌各亚型精准医疗策略研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 529-533.
[12]	李响, 胡洋, 张清媛. 肿瘤突变负荷作为乳腺癌免疫治疗的新兴生物标志物的研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 568-571.
[13]	周天虹, 顾秀瑛, 姚芳, 宋述铭. 乌鲁木齐市2014—2018年度乳腺癌筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(5): 391-395.
[14]	马补换, 刘彩霞. Jagged1促进乳腺癌发生发展及远处转移的研究进展[J]. 实用肿瘤学杂志, 2021, 35(5): 452-457.
[15]	秦朝, 李江, 郑亚迪, 王飞, 曹巍, 许永杰, 余一雯, 赵亮, 于欣阳, 陈宏达, 任建松, 王勇, 李静, 李霓, 陈万青. 中国城市乳腺癌高危人群筛查依从性及其相关因素分析[J]. 实用肿瘤学杂志, 2021, 35(4): 291-296.